Acute cigarette smoke exposure reduces clot lysis - Association between altered fibrin architecture and the response to t-PA

Thrombosis Research

Volumn 126, Issue 5, 2010, Pages 426-430

  Barua, Rajat S ^a   Sy, Fridolin ^a   Srikanth, Sundararajan ^a   Huang, Grace ^a   Javed, Usman ^a   Buhari, Cyrus ^a   Margosan, Dennis ^b   Aftab, Waqas ^a   Ambrose, John A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b San Joaquin Valley Agricultural Sciences Center   (United States)

Author keywords

Fibrin; Fibrinogen; Fibrinolysis; Smoking; Thrombolysis

Indexed keywords

ALTEPLASE; CIGARETTE SMOKE; FIBRIN; FIBRINOGEN; THROMBIN;

ADULT; ARTICLE; BLOOD CLOT LYSIS; CIGARETTE SMOKING; CONTROLLED STUDY; EX VIVO STUDY; HEART INFARCTION; HUMAN; HUMAN TISSUE; MALE; NORMAL HUMAN; PRIORITY JOURNAL; SHEAR STRESS; THROMBOCYTE POOR PLASMA; THROMBOELASTOGRAPHY; THROMBOGENICITY;

ADULT; BLOOD COAGULATION; BLOOD PLATELETS; CASE-CONTROL STUDIES; FIBRIN; HUMANS; MALE; RISK FACTORS; SMOKING; THROMBOSIS; TISSUE PLASMINOGEN ACTIVATOR;

EID: 78149280980     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2010.07.021     Document Type: Article

References (25)

1. J.A. Ambrose, and R.S. Barua The pathophysiology of cigarette smoking and cardiovascular disease: an update J Am Coll Cardiol 43 2004 1731 1737
2. A.P. Burke, A. Farb, G.T. Malcom, Y. Liang, J. Smialek, and R. Virmani Coronary risk factors and plaque morphology in men with coronary disease who died suddenly N Engl J Med 336 1997 1276 1282
3. R.S. Barua, J.A. Ambrose, D.C. Saha, and L.J. Eales-Reynolds Smoking is associated with altered endothelial-derived fibrinolytic and antithrombotic factors: an in vitro demonstration Circulation 106 2002 905 908
4. C.L. Grines, E.J. Topol, W.W. O'Neill, B.S. George, D. Kereiakes, H.R. Phillips, J.D. Leimberger, L.H. Woodlieff, and R.M. Califf Effect of cigarette smoking on outcome after thrombolytic therapy for myocardial infarction Circulation 91 1995 298 303
5. B.G. Angeja, S. Kermgard, M.S. Chen, M. McKay, S.A. Murphy, E.M. Antman, C.P. Cannon, E. Braunwald, and C.M. Gibson The smoker's paradox: insights from the angiographic substudies of the TIMI trials J Thromb Thrombolysis 13 2002 133 139
6. A.J. Kirtane, P. Martinezclark, A.M. Rahman, K.K. Ray, D. Karmpaliotis, S.A. Murphy, R.P. Giugliano, C.P. Cannon, E.M. Antman, M.T. Roe, R.A. Harrington, E.M. Ohman, E. Braunwald, and C.M. Gibson Association of smoking with improved myocardial perfusion and the angiographic characterization of myocardial tissue perfusion after fibrinolytic therapy for ST-segment elevation myocardial infarction J Am Coll Cardiol 45 2005 321 323
7. J.D. Mills, R.A. Ariëns, M.W. Mansfield, and P.J. Grant Altered fibrin clot structure in the healthy relatives of patients with premature coronary artery disease Circulation 106 2002 1938 1942
8. A. Undas, K. Szułdrzynski, E. Stepien, J. Zalewski, J. Godlewski, W. Tracz, M. Pasowicz, and K. Zmudka Reduced clot permeability and susceptibility to lysis in patients with acute coronary syndrome: effects of inflammation and oxidative stress Atherosclerosis 196 2008 551 557
9. E.M. Scott, R.A. Ariëns, and P.J. Grant Genetic and environmental determinants of fibrin structure and function: relevance to clinical disease Arterioscler Thromb Vasc Biol 24 2004 1558 1566
10. P.J. Grant Diabetes mellitus as a prothrombotic condition J Intern Med 262 2 2007 157 172
11. J.P. Collet, D. Park, C. Lesty, J. Soria, C. Soria, G. Montalescot, and J.W. Weisel Influence of fibrin network conformation and fibrin fiber diameter on fibrinolysis speed: dynamic and structural approaches by confocal microscopy Arterioscler Thromb Vasc Biol 20 2000 1354 1361
12. R.S. Barua, F. Sy, S. Srikanth, G. Huang, U. Javed, C. Buhari, D. Margosan, and J.A. Ambrose Effects of cigarette smoke exposure on clot dynamics and fibrin structure. An ex-vivo investigation Arterioscler Thromb Vasc Biol 30 2010 75 79
13. G.J. Shaw, N. Bavani, A. Dhamija, and C.J. Lindsell Effect of mild hypothermia on the thrombolytic efficacy of 120 ultrasound enhanced thrombolysis in an in-vitro human clot model Thromb Res 117 2006 603 608
14. R. Doll, and R. Peto Mortality in relation to smoking: 20 years' observations on male British doctors BMJ 2 1976 1525 1536
15. Centers for Disease Control and Prevention Annual smoking attributable mortality, years of potential life lost, and economic costs-United States, 1995-1999 MMWR Morb Mortal Wkly Rep 5 2002 300 303
16. D. Waters, J. Lesperance, P. Gladstone, S. Boccuzzi, T. Cook, R. Hudgin, G. Krip, and L. Higginson Effects of cigarette smoking on the angiographic evolution of coronary atherosclerosis: a Canadian Coronary Atherosclerosis Intervention trial (CCAIT) substudy: CCAIT Study Group Circulation 94 1996 614 621
17. T. Inoue, K. Oku, K. Kimoto, M. Takao, J. Nomoto, K. Handa, S. Kono, and K. Arakawa Relationship of cigarette smoking to the severity of coronary and thoracic aortic atherosclerosis Cardiology 86 1995 374 379
18. M.E. McKenzie, P.A. Gurbel, D.J. Levine, and V.L. Serebruany Clinical utility of available methods for determining platelet function Cardiology 92 1999 240 247
19. S.A. Mousa, S. Khurana, and M.S. Forsythe Comparative in vitro efficacy of different platelet glycoprotein IIb/IIIa antagonists on platelet-mediated clot strength induced by tissue factor with use of thromboelastography: differentiation among glycoprotein IIb/IIIa antagonists Arterioscler Thromb Vasc Biol 20 2000 1162 1167
20. R.S. Barua, J.A. Ambrose, S. Srivastava, M.C. DeVoe, and L.J. Eales-Reynolds Reactive oxygen species are involved in smoking-induced dysfunction of nitric oxide biosynthesis and upregulation of endothelial nitric oxide synthase: an in vitro demonstration in human coronary artery endothelial cells Circulation 107 2003 2342 2347
21. E. Shacter, J.A. Williams, M. Lim, and R.L. Levine Differential susceptibility of plasma proteins to oxidative modification: examination by western blot immunoassay Free Radic Biol Med 17 1994 429 437
22. Y.H. Feng, and G. Hart In vitro oxidative damage to tissue-type plasminogen activator: a selective modification of the biological functions Cardiovasc Res 30 1995 255 261
23. B.C. Lim, R.A. Ariëns, A.M. Carter, J.W. Weisel, and P.J. Grant Genetic regulation of fibrin structure and function: complex gene-environment interactions may modulate vascular risk Lancet 361 2003 1424 1431
24. C. Kobbervig, and E. Williams FXIII polymorphisms, fibrin clot structure and thrombotic risk Biophys Chem 112 2-3 Dec 20 2004 223 228
25. F. Marín, R. González-Conejero, K.W. Lee, J. Corral, V. Roldán, F. López, F. Sogorb, J. Caturla, G.Y. Lip, and V. Vicente A pharmacogenetic effect of factor XIII valine 34 leucine polymorphism on fibrinolytic therapy for acute myocardial infarction J Am Coll Cardiol 45 2005 25 29